LearySMPorterBThompsonAJ.Multiple sclerosis: Diagnosis and the management of acute relapses. Postgrad Med J2005; 81(955): 302–308.
2.
BenedictRHMorrowSRodgersJ, et al. Characterizing cognitive function during relapse in multiple sclerosis. Mult Scler2014; 20(13): 1745–1752.
3.
Bellmann-StroblJWuerfelJAktasO, et al. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology2009; 73(20): 1624–1627.
4.
PardiniMUccelliAGrafmanJ, et al. Isolated cognitive relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry2014; 85(9): 1035–1037.
5.
DamascenoADamascenoBPCendesF.Subclinical MRI disease activity influences cognitive performance in MS patients. Mult Scler Relat Disord2015; 4(2): 137–143.
6.
FenuGArruMLoreficeL, et al. Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study. Mult Scler Relat Disord2018; 23: 83–87.
7.
BenedictRHDeLucaJPhillipsG, et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler2017; 23(5): 721–773.
8.
MeliRRoccatagliataLCapelloE, et al. Ecological impact of isolated cognitive relapses in MS. Mult Scler2020; 26: 114–117.
9.
MatzaLSKimKPhillipsG, et al. Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews. Mult Scler Relat Disord2019; 27: 139–146.
10.
Di FilippoMPortaccioEManciniA, et al. Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nat Rev Neurosci2018;19(10): 599–609.
